Summary
Updated Aug 31, 2026
John A. Orwin files SEC Form 4 reports at First Tracks Biotherapeutics, Inc. (TRAX). 10 SEC Form 4 filings on record going back to 2025, most recently on 17 June 2026.
Recent Transactions
4Every recent SEC Form 4 transaction John A. Orwin has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies John A. Orwin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $65.00M of TRAX open-market activity in the last 12 months
- Daniel Faga - $2.14M of ANAB open-market activity in the last 12 months
- Eric J. Loumeau - $1.32M of ANAB open-market activity in the last 12 months
- John P. Schmid - $1.16M of ANAB open-market activity in the last 12 months
- Magda Marquet - $531K of ANAB open-market activity in the last 12 months
- Paul F. Lizzul - $264K of ANAB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is John A. Orwin?
John A. Orwin is a corporate insider of First Tracks Biotherapeutics, Inc. (TRAX). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John A. Orwin submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of John A. Orwin's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow John A. Orwin and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
